Boiron SA - Strategy and SWOT Report
Published: January 2013 · Publisher: MarketLine
Boiron SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Boiron SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Boiron SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boiron SA in the form of a SWOT analysis
- An in-depth view of the business model of Boiron SA including a breakdown and examination of key business segments
- Intelligence on Boiron SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boiron SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Boiron is a France-based pharmaceutical group specializing in homeopathic medicines. The group also markets medicines based on trace elements, food supplements and health and beauty care products. The group primarily operates in Europe and North America. Boiron is headquartered in Sainte Foy les Lyon, France and employed 4,081 people as of December 31, 2010. The group recorded revenues of E520.4 million ($690.4 million*) during the financial year (FY) ended December 2010, a decrease of 1.1% over FY2009. The operating profit of the group was E66.7 million ($88.4 million*) during FY2010, a decrease of 26.3% over FY2009. The net profit was E43.3 million ($57.4 million*) in FY2010, a decrease of 27.7% over FY2009. * Calculated using the constant conversion rate of E1 = $1.3267 during the financial year ended December 31, 2010.
Reasons to Purchase:
- Gain understanding of Boiron SA and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Boiron SA as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Boiron SA’s business structure, strategy and prospects
Features:
- Detailed information on Boiron SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boiron SA in the form of a SWOT analysis
- An in-depth view of the business model of Boiron SA including a breakdown and examination of key business segments
- Intelligence on Boiron SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boiron SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Boiron is a France-based pharmaceutical group specializing in homeopathic medicines. The group also markets medicines based on trace elements, food supplements and health and beauty care products. The group primarily operates in Europe and North America. Boiron is headquartered in Sainte Foy les Lyon, France and employed 4,081 people as of December 31, 2010. The group recorded revenues of E520.4 million ($690.4 million*) during the financial year (FY) ended December 2010, a decrease of 1.1% over FY2009. The operating profit of the group was E66.7 million ($88.4 million*) during FY2010, a decrease of 26.3% over FY2009. The net profit was E43.3 million ($57.4 million*) in FY2010, a decrease of 27.7% over FY2009. * Calculated using the constant conversion rate of E1 = $1.3267 during the financial year ended December 31, 2010.
Reasons to Purchase:
- Gain understanding of Boiron SA and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Boiron SA as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Boiron SA’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Boiron SA: Company Overview
Boiron SA: Overview and Key Facts
Boiron SA: Overview
Boiron SA: Key Facts
Boiron SA: Key Employees
Boiron SA: Key Employee Biographies
Boiron SA: Major Products and Services
Boiron SA: Company History
Boiron SA: Management Statement
Boiron SA: Locations and Subsidiaries
Boiron SA: Key Competitors
Boiron SA: Company Analysis
Boiron SA: Business Description
Boiron SA: SWOT Analysis
Boiron SA: SWOT Overview
Boiron SA: Strengths
Boiron SA: Weaknesses
Boiron SA: Opportunities
Boiron SA: Threats
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Boiron SA: Key Facts
Table 2: Boiron SA: Key Employees
Table 4: Boiron SA: Key Competitors
Boiron SA: Company Overview
Boiron SA: Overview and Key Facts
Boiron SA: Overview
Boiron SA: Key Facts
Boiron SA: Key Employees
Boiron SA: Key Employee Biographies
Boiron SA: Major Products and Services
Boiron SA: Company History
Boiron SA: Management Statement
Boiron SA: Locations and Subsidiaries
Boiron SA: Key Competitors
Boiron SA: Company Analysis
Boiron SA: Business Description
Boiron SA: SWOT Analysis
Boiron SA: SWOT Overview
Boiron SA: Strengths
Boiron SA: Weaknesses
Boiron SA: Opportunities
Boiron SA: Threats
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Boiron SA: Key Facts
Table 2: Boiron SA: Key Employees
Table 4: Boiron SA: Key Competitors
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.

